Steven Lister
Overview
Explore the profile of Steven Lister including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mulholland R, Ciminata G, Quinn T, Pollock K, Lister S, Geue C
Pharmacoeconomics
. 2024 Aug;
42(11):1241-1253.
PMID: 39093500
Background: Atrial fibrillation (AF) is associated with increased morbidity and mortality and exerts an increasingly significant burden on global healthcare resources, with its prevalence rising with an ageing population. Despite...
2.
Mulholland R, Manca F, Ciminata G, Quinn T, Trotter R, Pollock K, et al.
Eur Heart J Open
. 2024 Apr;
4(2):oeae016.
PMID: 38572087
Aims: Whilst anti-coagulation is typically recommended for thromboprophylaxis in atrial fibrillation (AF), it is often never prescribed or prematurely discontinued. The aim of this study was to evaluate the effect...
3.
Hutchings H, Lanyon K, Holland G, Alikhan R, Jenkins R, Laing H, et al.
BMJ Open
. 2023 Oct;
13(10):e075335.
PMID: 37802619
Objective: To evaluate the feasibility of recruiting participants diagnosed with atrial fibrillation (AF) taking oral anticoagulation therapies (OATs) and recently experiencing a bleed to collect health-related quality of life (HRQoL)...
4.
Harris D, Torabi F, Mallory D, Akbari A, Thayer D, Wang T, et al.
Eur Heart J Open
. 2023 May;
3(3):oead037.
PMID: 37143610
Aims: In patients with non-valvular atrial fibrillation (NVAF) prescribed warfarin, the association between guideline defined international normalised ratio (INR) control and adverse outcomes in unknown. We aimed to (i) determine...
5.
Lee K, Doudesis D, Bing R, Astengo F, Perez J, Anand A, et al.
J Am Heart Assoc
. 2023 Mar;
12(5):e027211.
PMID: 36864741
Background Important disparities in the treatment and outcomes of women and men with atrial fibrillation (AF) are well recognized. Whether introduction of direct oral anticoagulants has reduced disparities in treatment...
6.
Hutchings H, Lanyon K, Lister S, Alikhan R, Halcox J, Holland G, et al.
Pilot Feasibility Stud
. 2022 Aug;
8(1):180.
PMID: 35962446
Background: Oral anticoagulation therapies (OATs) are often prescribed in conjunction with medications to restore normal heart rate rhythm which can limit the risk of an atrial fibrillation (AF) related stroke...
7.
Hill N, Groves L, Dickerson C, Boyce R, Lawton S, Hurst M, et al.
J Med Econ
. 2022 Jul;
25(1):974-983.
PMID: 35834373
Objective: The PULsE-AI trial sought to determine the effectiveness of a screening strategy that included a machine learning risk prediction algorithm in conjunction with diagnostic testing for identification of undiagnosed...
8.
Szymanski T, Ashton R, Sekelj S, Petrungaro B, Pollock K, Sandler B, et al.
Europace
. 2022 Feb;
24(8):1240-1247.
PMID: 35226101
Aims: We investigated whether the use of an atrial fibrillation (AF) risk prediction algorithm could improve AF detection compared with opportunistic screening in primary care and assessed the associated budget...
9.
Harris D, Wang T, Lister S, Halcox J
Eur Heart J Cardiovasc Pharmacother
. 2021 Mar;
7(3):e27-e28.
PMID: 33734310
No abstract available.
10.
Hill N, Arden C, Beresford-Hulme L, Camm A, Clifton D, Davies D, et al.
Contemp Clin Trials
. 2020 Oct;
99:106191.
PMID: 33091585
Atrial fibrillation (AF) is associated with an increased risk of stroke, enhanced stroke severity, and other comorbidities. However, AF is often asymptomatic, and frequently remains undiagnosed until complications occur. Current...